FDA approves Aurobindo Pharma's generic Lotensin

WASHINGTON Generic drug manufacturer Aurobindo Pharma has received final approval from the Food and Drug Administration to manufacture a generic version of Novartis Pharmaceuticals’ drug Lotensin, the company announced Tuesday.

Benazepril hydrochloride, the drug’s chemical name, is used to treat hypertension. The FDA granted Aurobindo approval to manufacture tablets in 10 mg, 20 mg and 40 mg doses.

Based in Hyderabad, India, Aurobindo manufacturers generic medicines and active pharmaceutical ingredients. Its products include antibiotics and anti-retroviral drugs, CVS, CNS, gastroenterological drugs and anti-allergy drugs.